← Back to Search

THC for Type 2 Diabetes

Phase 1
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male subjects must be willing to use clinically acceptable method of contraception during the entire study
Females of child bearing potential must agree to use two methods of contraception during the entire study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will study the effects of THC on blood sugar metabolism and heart health in people with Type 2 diabetes.

Who is the study for?
Adults aged 21-70 with Type 2 Diabetes, a BMI over 25 kg/m2, and stable diabetes medication for at least 3 months can join. They must not use tobacco or THC products recently, have no significant illnesses or heart issues, and agree to contraception if of childbearing potential.Check my eligibility
What is being tested?
The trial is testing the effects of THC on glucose metabolism in Type 2 Diabetes patients compared to a placebo. Participants will undergo blood tests and other assessments before and after two weeks of treatment to measure changes.See study design
What are the potential side effects?
Potential side effects from THC may include anxiety, paranoia, mood changes, increased heart rate or low blood pressure. However, individuals with a history of severe reactions to cannabis are excluded from this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to use contraception throughout the study.
Select...
I agree to use two forms of birth control during the study.
Select...
I am a woman who cannot have children because I am either over a year post-menopausal or have been surgically sterilized.
Select...
I am between 21 and 70 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Glucose Uptake
Change in Vascular Endothelial Function

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active THCActive Control2 Interventions
Daily, inhaled, flexible dose of cannabis product with THC.
Group II: Placebo CannabisPlacebo Group2 Interventions
Daily, inhaled, flexible dose of cannabis product without THC.

Find a Location

Who is running the clinical trial?

Center for Medicinal Cannabis ResearchOTHER
18 Previous Clinical Trials
599 Total Patients Enrolled
Center For Medicinal Cannabis Research at UC San Diego HealthUNKNOWN
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,377 Total Patients Enrolled

Media Library

Placebo Clinical Trial Eligibility Overview. Trial Name: NCT05322213 — Phase 1
Type 2 Diabetes Research Study Groups: Active THC, Placebo Cannabis
Type 2 Diabetes Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05322213 — Phase 1
Placebo 2023 Treatment Timeline for Medical Study. Trial Name: NCT05322213 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent could Active THC prove deleterious for individuals?

"With limited data on the safety and efficacy of Active THC, our staff at Power rated this drug a 1 out of 3."

Answered by AI

Could I potentially qualify for participation in this trial?

"This trial seeks 30 participants who have been medically diagnosed with type 2 diabetes mellitus and are within the ages of 21 to 70. Enrollees must meet multiple requirements, such as: a BMI greater than 25 kg/m2; an HbA1c level lower than 10%; providing written consent approved by IRB; being male or female; abstaining from certain substances at screening visit (if applicable); using contraception if capable of bearing children; etc."

Answered by AI

Does this trial encompass individuals of an advanced age?

"To be eligible for this trial, applicants must range in age from 21 to 70. For those younger or older than the indicated criteria, there are 193 clinical trials catering towards minors and 1103 studies catered towards seniors."

Answered by AI

Is this medical investigation presently recruiting participants?

"Unfortunately, clinicaltrials.gov reports that no patients are being recruited for this trial as of now. It was posted on August 1st and last updated April 8th 2022, but 1441 other trials remain in search of volunteers at present."

Answered by AI
~20 spots leftby Feb 2027